|
ATF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.963600E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.224500E-03 |
| Normal-vs-Stage2 |
9.618400E-04 |
| Normal-vs-Stage3 |
3.825200E-04 |
| Normal-vs-Stage4 |
1.019150E-04 |
| Stage1-vs-Stage2 |
1.060620E-01 |
| Stage1-vs-Stage3 |
1.538010E-01 |
| Stage1-vs-Stage4 |
4.873700E-02 |
| Stage2-vs-Stage3 |
5.804000E-01 |
| Stage2-vs-Stage4 |
8.094400E-01 |
| Stage3-vs-Stage4 |
3.858000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.781300E-04 |
| Normal-vs-AfricanAmerican |
2.915000E-01 |
| Normal-vs-Asian |
5.755800E-02 |
| Caucasian-vs-AfricanAmerican |
4.125600E-01 |
| Caucasian-vs-Asian |
6.418200E-01 |
| AfricanAmerican-vs-Asian |
6.991600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.31210000000748E-05 |
| Normal-vs-Female |
1.843900E-03 |
| Male-vs-Female |
5.827600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.773700E-02 |
| Normal-vs-Age(41-60Yrs) |
3.961300E-04 |
| Normal-vs-Age(61-80Yrs) |
6.24379999999425E-05 |
| Normal-vs-Age(81-100Yrs) |
1.118230E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.460990E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.781980E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.831400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.110200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.662800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.020600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.507900E-02 |
| Classical-VS-Follicular |
1.041060E-03 |
| Classical-VS-Other |
3.127000E-01 |
| Classical-VS-Normal |
2.766000E-02 |
| Tall-VS-Follicular |
5.604600E-01 |
| Tall-VS-Other |
8.351000E-01 |
| Tall-VS-Normal |
1.141250E-03 |
| Follicular-VS-Other |
9.322800E-01 |
| Follicular-VS-Normal |
2.07139999999217E-05 |
| Other-VS-Normal |
4.468300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.85000000000524E-05 |
| Normal-vs-N1 |
2.695900E-03 |
| N0-vs-N1 |
8.821200E-01 |
|
|
